QUEBEC CITY, April 20 /CNW Telbec/ - AEterna Zentaris Inc. (TSX: AEZ;
NASDAQ: AEZS) today announced it gained market approval for Cetrotide(R)
(cetrorelix) in Japan for in vitro fertilization. Cetrotide(R) (cetrorelix)
will be manufactured and marketed in Japan by partners Nippon Kayaku Co., Ltd.
and Shionogi & Co., Ltd. AEterna Zentaris obtained an undisclosed milestone
payment from its partners and will receive revenues from the supply of
Cetrotide(R) (cetrorelix) to its Japanese partners. Cetrotide(R) (cetrorelix)
is expected to be launched in Japan by year-end.
